CVS · 10-Q · 2026Q2 · Full report
Liquidity and Debt Position
CVS HEALTH Corp · 2026-08-05 · Importance 19 · Surprise 6 · In source text
CVS Health had no commercial paper outstanding and no borrowings under its three unsecured back-up revolving credit facilities as of June 30, 2026. Each facility provides $2.5 billion of capacity and expires in May 2029, 2030, or 2031, for total revolving capacity of $7.5 billion. A subsidiary also had approximately $1.3 billion of borrowing capacity available from the Federal Home Loan Bank of Boston, with no outstanding advances. Long-term debt was rated BBB by Fitch, Baa3 by Moody’s, and BBB by S&P, while Fitch maintained a negative outlook and Moody’s a stable outlook; S&P changed its outlook from negative to stable in May 2026.
Key facts
- Net cash used in financing activities for the six months ended June 30, 2026 was $(5,011) million, an increase in use of $3,485 million or 228.4% versus prior year primarily due to higher repayments of long-term debt. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | -1.4% | Net cash used in financing activities for the six months ended June 30, 2026 was $(5,011) million, an increase in use of $3,485 million or… |
| liability | positive | realized | — | Net cash used in financing activities for the six months ended June 30, 2026 was $(5,011) million, an increase in use of $3,485 million or… |